{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:53Z","timestamp":1791859073487,"version":"4.3.4"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41581-025-00967-w","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:00:42Z","timestamp":1747908042000},"page":"525-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chronic kidney disease and dementia: an epidemiological perspective"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0372-8585","authenticated-orcid":false,"given":"M. Arfan","family":"Ikram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"967_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases, G. B. D. & Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 396, 1204\u20131222 (2020).","journal-title":"Lancet"},{"key":"967_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.14283\/jpad.2023.35","volume":"10","author":"HC Chi","year":"2023","unstructured":"Chi, H. C. et al. Adult renal dysfunction and risk of dementia or cognitive decline: brain-kidney axis hypothesis based on a systematic review and meta-analysis. J. Prev. Alzheimers Dis. 10, 443\u2013452 (2023).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"967_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002741","volume":"16","author":"S Licher","year":"2019","unstructured":"Licher, S. et al. Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: a population-based cohort study. PLoS Med. 16, e1002741 (2019).","journal-title":"PLoS Med."},{"key":"967_CR4","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S2214-109X(24)00050-0","volume":"12","author":"M Jadoul","year":"2024","unstructured":"Jadoul, M., Aoun, M. & Masimango Imani, M. The major global burden of chronic kidney disease. Lancet Glob. Health 12, e342\u2013e343 (2024).","journal-title":"Lancet Glob. Health"},{"key":"967_CR5","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes, CKD Work Group.","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes, CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"key":"967_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators.","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol. 23, 344\u2013381 (2024).","journal-title":"Lancet Neurol."},{"key":"967_CR7","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"967_CR8","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1001\/jamaneurol.2023.3664","volume":"80","author":"RC Petersen","year":"2023","unstructured":"Petersen, R. C. et al. A new framework for dementia nomenclature. JAMA Neurol. 80, 1364\u20131370 (2023).","journal-title":"JAMA Neurol."},{"key":"967_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois, B. et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the international working group. Lancet Neurol. 20, 484\u2013496 (2021).","journal-title":"Lancet Neurol."},{"key":"967_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12882-024-03466-5","volume":"25","author":"DR Farrell","year":"2024","unstructured":"Farrell, D. R. & Vassalotti, J. A. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? BMC Nephrol. 25, 34 (2024).","journal-title":"BMC Nephrol."},{"key":"967_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2013.243","volume":"84","author":"KM Andrassy","year":"2013","unstructured":"Andrassy, K. M. Comments on \u2018KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u2019. Kidney Int. 84, 622\u2013623 (2013).","journal-title":"Kidney Int."},{"key":"967_CR12","unstructured":"Vaidya, S. R., Aeddula, N. R. & Doerr, C. Chronic kidney disease (nursing). In StatPearls https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK568778\/ (2024)."},{"key":"967_CR13","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello, A. K. et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob. Health 12, e382\u2013e395 (2024).","journal-title":"Lancet Glob. Health"},{"key":"967_CR14","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators.","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public. Health 7, e105\u2013e125 (2022).","journal-title":"Lancet Public. Health"},{"key":"967_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet 404, 572\u2013628 (2024).","journal-title":"Lancet"},{"key":"967_CR16","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1212\/WNL.0000000000010022","volume":"95","author":"FJ Wolters","year":"2020","unstructured":"Wolters, F. J. et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer cohorts consortium. Neurology 95, e519\u2013e531 (2020).","journal-title":"Neurology"},{"key":"967_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41569-019-0202-5","volume":"16","author":"C Andersson","year":"2019","unstructured":"Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D. & Vasan, R. S. 70-year legacy of the Framingham Heart Study. Nat. Rev. Cardiol. 16, 687\u2013698 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"967_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/oxfordjournals.aje.a116678","volume":"137","author":"MB Mittelmark","year":"1993","unstructured":"Mittelmark, M. B. et al. Prevalence of cardiovascular diseases among older adults. Cardiovascular health study. Am. J. Epidemiol. 137, 311\u2013317 (1993).","journal-title":"Am. J. Epidemiol."},{"key":"967_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10654-023-01094-1","volume":"39","author":"MA Ikram","year":"2024","unstructured":"Ikram, M. A. et al. The Rotterdam study. Design update and major findings between 2020 and 2024. Eur. J. Epidemiol. 39, 183\u2013206 (2024).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","volume":"129","author":"The Atherosclerosis Risk In Communities (ARIC) study: design and objectives.","year":"1989","unstructured":"The Atherosclerosis Risk In Communities (ARIC) study: design and objectives. The ARIC investigators. Am J Epidemiol 129, 687\u2013702 (1989).","journal-title":"Am J Epidemiol"},{"key":"967_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","volume":"156","author":"DE Bild","year":"2002","unstructured":"Bild, D. E. et al. Multi-ethnic study of atherosclerosis: objectives and design. Am. J. Epidemiol. 156, 871\u2013881 (2002).","journal-title":"Am. J. Epidemiol."},{"key":"967_CR22","doi-asserted-by":"publisher","first-page":"m131","DOI":"10.1136\/bmj.m131","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty, G. D., Gale, C. R., Kivim\u00e4ki, M., Deary, I. J. & Bell, S. Comparison of risk factor associations in UK biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ 368, m131 (2020).","journal-title":"BMJ"},{"key":"967_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","volume":"70","author":"JM Gaziano","year":"2016","unstructured":"Gaziano, J. M. et al. Million Veteran Program: a mega-biobank to study genetic influences on health and disease. J. Clin. Epidemiol. 70, 214\u2013223 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"967_CR24","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10654-022-00890-5","volume":"37","author":"A Peters","year":"2022","unstructured":"Peters, A. et al. Framework and baseline examination of the German national cohort (NAKO). Eur. J. Epidemiol. 37, 1107\u20131124 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR25","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s40620-024-02047-x","volume":"37","author":"E Stefanou","year":"2024","unstructured":"Stefanou, E., Tountas, C., Ioannidis, E. & Kole, C. Biomarkers in cardiorenal syndrome, a potential use in precision medicine. J. Nephrol. 37, 2127\u20132138 (2024).","journal-title":"J. Nephrol."},{"key":"967_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40620-024-01887-x","volume":"37","author":"M Provenzano","year":"2024","unstructured":"Provenzano, M. et al. Estimated glomerular filtration rate in observational and interventional studies in chronic kidney disease. J. Nephrol. 37, 573\u2013586 (2024).","journal-title":"J. Nephrol."},{"key":"967_CR27","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N. Engl. J. Med. 385, 1737\u20131749 (2021).","journal-title":"N. Engl. J. Med."},{"key":"967_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuro.2014.06.014","volume":"44","author":"K Watanabe","year":"2014","unstructured":"Watanabe, K., Watanabe, T. & Nakayama, M. Cerebro-renal interactions: impact of uremic toxins on cognitive function. Neurotoxicology 44, 184\u2013193 (2014).","journal-title":"Neurotoxicology"},{"key":"967_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1567205019666220120113305","volume":"19","author":"Y Zheng","year":"2022","unstructured":"Zheng, Y., Ji, B., Chen, S., Zhou, R. & Ni, R. The impact of uremic toxins on Alzheimer\u2019s disease. Curr. Alzheimer Res. 19, 104\u2013118 (2022).","journal-title":"Curr. Alzheimer Res."},{"key":"967_CR30","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1681\/ASN.2021010094","volume":"32","author":"JH Greenberg","year":"2021","unstructured":"Greenberg, J. H. et al. Urine biomarkers of kidney tubule health, injury, and inflammation are associated with progression of CKD in children. J. Am. Soc. Nephrol. 32, 2664\u20132677 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR31","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/jmri.29000","volume":"59","author":"K Zhao","year":"2024","unstructured":"Zhao, K., Seeliger, E., Niendorf, T. & Liu, Z. Noninvasive assessment of diabetic kidney disease with MRI: hype or hope? J. Magn. Reson. Imaging 59, 1494\u20131513 (2024).","journal-title":"J. Magn. Reson. Imaging"},{"key":"967_CR32","doi-asserted-by":"publisher","first-page":"100464","DOI":"10.1016\/j.xkme.2022.100464","volume":"4","author":"RK Singla","year":"2022","unstructured":"Singla, R. K., Kadatz, M., Rohling, R. & Nguan, C. Kidney ultrasound for nephrologists: a review. Kidney Med. 4, 100464 (2022).","journal-title":"Kidney Med."},{"key":"967_CR33","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"967_CR34","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jalz.2019.03.013","volume":"15","author":"SKL Darweesh","year":"2019","unstructured":"Darweesh, S. K. L. et al. Quantitative gait, cognitive decline, and incident dementia: the Rotterdam study. Alzheimers Dement. 15, 1264\u20131273 (2019).","journal-title":"Alzheimers Dement."},{"key":"967_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002143","volume":"13","author":"FJ Wolters","year":"2016","unstructured":"Wolters, F. J. et al. Orthostatic hypotension and the long-term risk of dementia: a population-based study. PLoS Med. 13, e1002143 (2016).","journal-title":"PLoS Med."},{"key":"967_CR36","first-page":"1438","volume":"15","author":"SS Mooldijk","year":"2024","unstructured":"Mooldijk, S. S. & Ikram, M. A. Cerebral small vessel disease in population-based research: what are we looking at \u2014 and what not? Aging Dis. 15, 1438\u20131446 (2024).","journal-title":"Aging Dis."},{"key":"967_CR37","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1474-4422(22)00298-8","volume":"21","author":"CR Jack Jr","year":"2022","unstructured":"Jack, C. R. Jr Advances in Alzheimer\u2019s disease research over the past two decades. Lancet Neurol. 21, 866\u2013869 (2022).","journal-title":"Lancet Neurol."},{"key":"967_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.123.19943","volume":"81","author":"AH Hainsworth","year":"2024","unstructured":"Hainsworth, A. H., Markus, H. S. & Schneider, J. A. Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia. Hypertension 81, 75\u201386 (2024).","journal-title":"Hypertension"},{"key":"967_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101762","volume":"82","author":"X Tang","year":"2022","unstructured":"Tang, X. et al. Association of kidney function and brain health: a systematic review and meta-analysis of cohort studies. Ageing Res. Rev. 82, 101762 (2022).","journal-title":"Ageing Res. Rev."},{"key":"967_CR40","doi-asserted-by":"publisher","first-page":"100249","DOI":"10.1016\/j.alcr.2018.10.002","volume":"41","author":"M Mund","year":"2019","unstructured":"Mund, M. & Nestler, S. Beyond the cross-lagged panel model: next-generation statistical tools for analyzing interdependencies across the life course. Adv. Life Course Res. 41, 100249 (2019).","journal-title":"Adv. Life Course Res."},{"key":"967_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000524475","volume":"8","author":"Z Xie","year":"2022","unstructured":"Xie, Z., Tong, S., Chu, X., Feng, T. & Geng, M. Chronic kidney disease and cognitive impairment: the kidney-brain axis. Kidney Dis. 8, 275\u2013285 (2022).","journal-title":"Kidney Dis."},{"key":"967_CR42","doi-asserted-by":"publisher","first-page":"830064","DOI":"10.3389\/fneur.2022.830064","volume":"13","author":"DM Kelly","year":"2022","unstructured":"Kelly, D. M. & Rothwell, P. M. Disentangling the relationship between chronic kidney disease and cognitive disorders. Front. Neurol. 13, 830064 (2022).","journal-title":"Front. Neurol."},{"key":"967_CR43","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s40620-024-01929-4","volume":"37","author":"M Bossola","year":"2024","unstructured":"Bossola, M. & Picconi, B. Uremic toxins and the brain in chronic kidney disease. J. Nephrol. 37, 1391\u20131395 (2024).","journal-title":"J. Nephrol."},{"key":"967_CR44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrneph.2015.131","volume":"11","author":"R Lu","year":"2015","unstructured":"Lu, R., Kiernan, M. C., Murray, A., Rosner, M. H. & Ronco, C. Kidney-brain crosstalk in the acute and chronic setting. Nat. Rev. Nephrol. 11, 707\u2013719 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"967_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000430922","volume":"41","author":"SL Seliger","year":"2015","unstructured":"Seliger, S. L., Wendell, C. R., Waldstein, S. R., Ferrucci, L. & Zonderman, A. B. Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging. Am. J. Nephrol. 41, 305\u2013312 (2015).","journal-title":"Am. J. Nephrol."},{"key":"967_CR46","doi-asserted-by":"publisher","first-page":"349.e1","DOI":"10.1016\/j.jamda.2014.12.009","volume":"16","author":"S Lee","year":"2015","unstructured":"Lee, S. et al. The association between kidney function and cognitive decline in community-dwelling, elderly Japanese people. J. Am. Med. Dir. Assoc. 16, 349.e1\u20135 (2015).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"967_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0745-9","volume":"14","author":"I Berger","year":"2016","unstructured":"Berger, I. et al. Cognition in chronic kidney disease: a systematic review and meta-analysis. BMC Med. 14, 206 (2016).","journal-title":"BMC Med."},{"key":"967_CR48","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1681\/ASN.2012050536","volume":"24","author":"JM Bugnicourt","year":"2013","unstructured":"Bugnicourt, J. M., Godefroy, O., Chillon, J. M., Choukroun, G. & Massy, Z. A. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J. Am. Soc. Nephrol. 24, 353\u2013363 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR49","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/ndt\/gfae079","volume":"39","author":"DM Kelly","year":"2024","unstructured":"Kelly, D. M., et al. Impaired kidney function, cerebral small vessel disease and cognitive disorders: the Framingham Heart Study. Nephrol. Dial. Transplant. 39, 1911\u20131922 (2024).","journal-title":"Nephrol. Dial. Transplant."},{"key":"967_CR50","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.kint.2018.04.022","volume":"94","author":"S Sedaghat","year":"2018","unstructured":"Sedaghat, S. et al. The AGES-Reykjavik study suggests that change in kidney measures is associated with subclinical brain pathology in older community-dwelling persons. Kidney Int. 94, 608\u2013615 (2018).","journal-title":"Kidney Int."},{"key":"967_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1212\/WNL.0000000000001741","volume":"85","author":"S Sedaghat","year":"2015","unstructured":"Sedaghat, S. et al. Kidney function and microstructural integrity of brain white matter. Neurology 85, 154\u2013161 (2015).","journal-title":"Neurology"},{"key":"967_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.ajkd.2022.07.013","volume":"81","author":"JB Scheppach","year":"2023","unstructured":"Scheppach, J. B. et al. Association of kidney function measures with signs of neurodegeneration and small vessel disease on brain magnetic resonance imaging: the Atherosclerosis Risk In Communities (ARIC) study. Am. J. Kidney Dis. 81, 261\u2013269.e1 (2023).","journal-title":"Am. J. Kidney Dis."},{"key":"967_CR53","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ijs.12465","volume":"10","author":"S Akoudad","year":"2015","unstructured":"Akoudad, S. et al. Kidney function and cerebral small vessel disease in the general population. Int. J. Stroke 10, 603\u2013608 (2015).","journal-title":"Int. J. Stroke"},{"key":"967_CR54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1681\/ASN.2014111118","volume":"27","author":"S Sedaghat","year":"2016","unstructured":"Sedaghat, S. et al. Kidney function and cerebral blood flow: the Rotterdam study. J. Am. Soc. Nephrol. 27, 715\u2013721 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR55","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1681\/ASN.2005010006","volume":"16","author":"SL Seliger","year":"2005","unstructured":"Seliger, S. L. et al. Cystatin C and subclinical brain infarction. J. Am. Soc. Nephrol. 16, 3721\u20133727 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.kint.2020.01.039","volume":"98","author":"TE Farrah","year":"2020","unstructured":"Farrah, T. E., Dhillon, B., Keane, P. A., Webb, D. J. & Dhaun, N. The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons. Kidney Int. 98, 323\u2013342 (2020).","journal-title":"Kidney Int."},{"key":"967_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5853\/jos.2015.17.1.31","volume":"17","author":"K Toyoda","year":"2015","unstructured":"Toyoda, K. Cerebral small vessel disease and chronic kidney disease. J. Stroke 17, 31\u201337 (2015).","journal-title":"J. Stroke"},{"key":"967_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106626","volume":"200","author":"Q Yan","year":"2024","unstructured":"Yan, Q. et al. Kidney\u2013brain axis in the pathogenesis of cognitive impairment. Neurobiol. Dis. 200, 106626 (2024).","journal-title":"Neurobiol. Dis."},{"key":"967_CR59","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","volume":"16","author":"D Viggiano","year":"2020","unstructured":"Viggiano, D. et al. Mechanisms of cognitive dysfunction in CKD. Nat. Rev. Nephrol. 16, 452\u2013469 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"967_CR60","first-page":"10","volume":"35","author":"D Viggiano","year":"2020","unstructured":"Viggiano, D. et al. Mild cognitive impairment and kidney disease: clinical aspects. Nephrol. Dial. Transpl. 35, 10\u201317 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"967_CR61","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1681\/ASN.V133806","volume":"13","author":"DH Kang","year":"2002","unstructured":"Kang, D. H. et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13, 806\u2013816 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR62","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/01.HYP.0000168052.00426.65","volume":"46","author":"MF O\u2019Rourke","year":"2005","unstructured":"O\u2019Rourke, M. F. & Safar, M. E. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46, 200\u2013204 (2005).","journal-title":"Hypertension"},{"key":"967_CR63","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1681\/ASN.2020010038","volume":"31","author":"M Kurella Tamura","year":"2020","unstructured":"Kurella Tamura, M. et al. Kidney disease, intensive hypertension treatment, and risk for dementia and mild cognitive impairment: the systolic blood pressure intervention trial. J. Am. Soc. Nephrol. 31, 2122\u20132132 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.ajkd.2023.03.012","volume":"82","author":"S Babroudi","year":"2023","unstructured":"Babroudi, S. et al. Blood pressure, incident cognitive impairment, and severity of CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am. J. Kidney Dis. 82, 443\u2013453.e1 (2023).","journal-title":"Am. J. Kidney Dis."},{"key":"967_CR65","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.ajkd.2018.04.018","volume":"72","author":"ED Kim","year":"2018","unstructured":"Kim, E. D. et al. Associations between kidney disease measures and regional pulse wave velocity in a large community-based cohort: the Atherosclerosis Risk In Communities (ARIC) study. Am. J. Kidney Dis. 72, 682\u2013690 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"967_CR66","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinte.158.7.761","volume":"158","author":"RE Zierler","year":"1998","unstructured":"Zierler, R. E. et al. Carotid and lower extremity arterial disease in patients with renal artery atherosclerosis. Arch. Intern. Med. 158, 761\u2013767 (1998).","journal-title":"Arch. Intern. Med."},{"key":"967_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s100169900109","volume":"12","author":"M Miralles","year":"1998","unstructured":"Miralles, M. et al. Screening for carotid and renal artery stenoses in patients with aortoiliac disease. Ann. Vasc. Surg. 12, 17\u201322 (1998).","journal-title":"Ann. Vasc. Surg."},{"key":"967_CR68","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1097\/01.ASN.0000136133.28194.E4","volume":"15","author":"TY Wong","year":"2004","unstructured":"Wong, T. Y. et al. Retinal microvascular abnormalities and renal dysfunction: the Atherosclerosis Risk In Communities study. J. Am. Soc. Nephrol. 15, 2469\u20132476 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR69","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/01.STR.0000221308.94473.14","volume":"37","author":"MS Fernando","year":"2006","unstructured":"Fernando, M. S. et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37, 1391\u20131398 (2006).","journal-title":"Stroke"},{"key":"967_CR70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2021.10.008","volume":"341","author":"JD Theuerle","year":"2022","unstructured":"Theuerle, J. D. et al. Retinal microvascular function predicts chronic kidney disease in patients with cardiovascular risk factors. Atherosclerosis 341, 63\u201370 (2022).","journal-title":"Atherosclerosis"},{"key":"967_CR71","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0140-6736(13)61088-0","volume":"383","author":"AI Qureshi","year":"2014","unstructured":"Qureshi, A. I. & Caplan, L. R. Intracranial atherosclerosis. Lancet 383, 984\u2013998 (2014).","journal-title":"Lancet"},{"key":"967_CR72","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.STR.26.1.14","volume":"26","author":"RL Sacco","year":"1995","unstructured":"Sacco, R. L., Kargman, D. E., Gu, Q. & Zamanillo, M. C. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 26, 14\u201320 (1995).","journal-title":"Stroke"},{"key":"967_CR73","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1747-4949.2006.00045.x","volume":"1","author":"LK Wong","year":"2006","unstructured":"Wong, L. K. Global burden of intracranial atherosclerosis. Int. J. Stroke 1, 158\u2013159 (2006).","journal-title":"Int. J. Stroke"},{"key":"967_CR74","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1161\/STROKEAHA.107.505776","volume":"39","author":"PB Gorelick","year":"2008","unstructured":"Gorelick, P. B., Wong, K. S., Bae, H. J. & Pandey, D. K. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 39, 2396\u20132399 (2008).","journal-title":"Stroke"},{"key":"967_CR75","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick, P. B. et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42, 2672\u20132713 (2011).","journal-title":"Stroke"},{"key":"967_CR76","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1681\/ASN.0000000000000459","volume":"35","author":"NM Pajewski","year":"2024","unstructured":"Pajewski, N. M. et al. The legacy effect of intensive versus standard BP control on the incidence of needing dialysis or kidney transplantation. J. Am. Soc. Nephrol. 35, 1737\u20131745 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR77","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/alz.12466","volume":"18","author":"JA Syrjanen","year":"2022","unstructured":"Syrjanen, J. A. et al. Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities. Alzheimers Dement. 18, 1128\u20131140 (2022).","journal-title":"Alzheimers Dement."},{"key":"967_CR78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JAD-220765","volume":"92","author":"S Sedaghat","year":"2023","unstructured":"Sedaghat, S. et al. The association of kidney function with plasma amyloid-\u03b2 levels and brain amyloid deposition. J. Alzheimers Dis. 92, 229\u2013239 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"967_CR79","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00415-023-12153-8","volume":"271","author":"J Sarto","year":"2024","unstructured":"Sarto, J. et al. Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort. J. Neurol. 271, 1973\u20131984 (2024).","journal-title":"J. Neurol."},{"key":"967_CR80","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1212\/WNL.0000000000207419","volume":"101","author":"A Dittrich","year":"2023","unstructured":"Dittrich, A. et al. Association of chronic kidney disease with plasma NfL and other biomarkers of neurodegeneration: the H70 Birth Cohort Study in Gothenburg. Neurology 101, e277\u2013e288 (2023).","journal-title":"Neurology"},{"key":"967_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13195-024-01401-2","volume":"16","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study. Alzheimers Res. Ther. 16, 32 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"967_CR82","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphar.2017.00370","volume":"8","author":"S Adesso","year":"2017","unstructured":"Adesso, S. et al. Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia. Front. Pharmacol. 8, 370 (2017).","journal-title":"Front. Pharmacol."},{"key":"967_CR83","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","volume":"94","author":"SA Lipton","year":"1997","unstructured":"Lipton, S. A. et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl Acad. Sci. USA 94, 5923\u20135928 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"967_CR84","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators.","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1223\u20131249 (2020).","journal-title":"Lancet"},{"key":"967_CR85","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","volume":"11","author":"N Stefan","year":"2023","unstructured":"Stefan, N. & Schulze, M. B. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 11, 426\u2013440 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"967_CR86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/2047487319886404","volume":"26","author":"PM Nilsson","year":"2019","unstructured":"Nilsson, P. M., Tuomilehto, J. & Ryd\u00e9n, L. The metabolic syndrome \u2014 what is it and how should it be managed? Eur. J. Prev. Cardiol. 26, 33\u201346 (2019).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"967_CR87","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539\u2013553 (1998).","journal-title":"Diabet. Med."},{"key":"967_CR88","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10654-022-00923-z","volume":"37","author":"AD Kjaergaard","year":"2022","unstructured":"Kjaergaard, A. D. et al. Kidney function and risk of dementia: observational study, meta-analysis, and two-sample mendelian randomization study. Eur. J. Epidemiol. 37, 1273\u20131284 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR89","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JAD-240807","volume":"102","author":"H Zhao","year":"2024","unstructured":"Zhao, H., Yuan, H. & Wang, E. Causal effects of kidney function and chronic kidney disease on Alzheimer\u2019s disease by analyzing large-scale genome-wide association study datasets. J. Alzheimers Dis. 102, 321\u2013328 (2024).","journal-title":"J. Alzheimers Dis."},{"key":"967_CR90","doi-asserted-by":"publisher","first-page":"e2581","DOI":"10.1212\/WNL.0000000000009642","volume":"94","author":"S Marini","year":"2020","unstructured":"Marini, S. et al. Genetic overlap and causal inferences between kidney function and cerebrovascular disease. Neurology 94, e2581\u2013e2591 (2020).","journal-title":"Neurology"},{"key":"967_CR91","doi-asserted-by":"publisher","first-page":"11233","DOI":"10.3390\/ijerph182111233","volume":"18","author":"DJ Pohl","year":"2021","unstructured":"Pohl, D. J. et al. Relationship between residential segregation, later-life cognition, and incident dementia across race\/ethnicity. Int. J. Env. Res. Public. Health 18, 11233 (2021).","journal-title":"Int. J. Env. Res. Public. Health"},{"key":"967_CR92","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s40615-020-00708-8","volume":"7","author":"H Lee","year":"2020","unstructured":"Lee, H., Caldwell, J. T., Maene, C., Cagney, K. A. & Saunders, M. R. Racial\/ethnic inequities in access to high-quality dialysis treatment in Chicago: does neighborhood racial\/ethnic composition matter? J. Racial Ethn. Health Disparities 7, 854\u2013864 (2020).","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"967_CR93","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/ckj\/sfac020","volume":"15","author":"S Park","year":"2022","unstructured":"Park, S. et al. Association between visit-to-visit blood pressure variability and risks of dementia in CKD patients: a nationwide observational cohort study. Clin. Kidney J. 15, 1506\u20131513 (2022).","journal-title":"Clin. Kidney J."},{"key":"967_CR94","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1159\/000500041","volume":"49","author":"DA Drew","year":"2019","unstructured":"Drew, D. A. et al. Blood pressure and cognitive decline in prevalent hemodialysis patients. Am. J. Nephrol. 49, 460\u2013469 (2019).","journal-title":"Am. J. Nephrol."},{"key":"967_CR95","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.3390\/ijerph19042389","volume":"19","author":"P Olczyk","year":"2022","unstructured":"Olczyk, P., Kusztal, M., Go\u0142\u0119biowski, T., Letachowicz, K. & Krajewska, M. Cognitive impairment in end stage renal disease patients undergoing hemodialysis: markers and risk factors. Int. J. Env. Res. Public. Health 19, 2389 (2022).","journal-title":"Int. J. Env. Res. Public. Health"},{"key":"967_CR96","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.mayocp.2024.04.017","volume":"99","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Association between cognitive function and risk of chronic kidney disease: a longitudinal cohort and mendelian randomization study. Mayo Clin. Proc. 99, 1399\u20131410 (2024).","journal-title":"Mayo Clin. Proc."},{"key":"967_CR97","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10654-018-0439-z","volume":"33","author":"SA Hayat","year":"2018","unstructured":"Hayat, S. A. et al. Understanding the relationship between cognition and death: a within cohort examination of cognitive measures and mortality. Eur. J. Epidemiol. 33, 1049\u20131062 (2018).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR98","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.kint.2019.10.032","volume":"97","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. & Okusa, M. D. Crosstalk between the nervous system and the kidney. Kidney Int. 97, 466\u2013476 (2020).","journal-title":"Kidney Int."},{"key":"967_CR99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021758118","volume":"118","author":"S Tanaka","year":"2021","unstructured":"Tanaka, S. et al. Vagus nerve stimulation activates two distinct neuroimmune circuits converging in the spleen to protect mice from kidney injury. Proc. Natl Acad. Sci. USA 118, e2021758118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"967_CR100","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/aje\/kwae162","volume":"194","author":"SS Mooldijk","year":"2025","unstructured":"Mooldijk, S. S., Labrecque, J. A., Ikram, M. A. & Ikram, M. K. Ratios in regression analyses with causal questions. Am J Epidemiol 194, 311\u2013313 (2025).","journal-title":"Am J Epidemiol"},{"key":"967_CR101","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","volume":"163","author":"MA Brookhart","year":"2006","unstructured":"Brookhart, M. A. et al. Variable selection for propensity score models. Am. J. Epidemiol. 163, 1149\u20131156 (2006).","journal-title":"Am. J. Epidemiol."},{"key":"967_CR102","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1016\/j.jclinepi.2019.08.011","volume":"114","author":"JA Knottnerus","year":"2019","unstructured":"Knottnerus, J. A. & Tugwell, P. Confounding obscures our view, effect modification is part of reality. J. Clin. Epidemiol. 114, v\u2013vi (2019).","journal-title":"J. Clin. Epidemiol."},{"key":"967_CR103","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ije\/dyr218","volume":"41","author":"MJ Knol","year":"2012","unstructured":"Knol, M. J. & VanderWeele, T. J. Recommendations for presenting analyses of effect modification and interaction. Int. J. Epidemiol. 41, 514\u2013520 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"967_CR104","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/EDE.0000000000000121","volume":"25","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele, T. J. A unification of mediation and interaction: a 4-way decomposition. Epidemiology 25, 749\u2013761 (2014).","journal-title":"Epidemiology"},{"key":"967_CR105","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10654-015-0087-5","volume":"30","author":"MA Ikram","year":"2015","unstructured":"Ikram, M. A. & VanderWeele, T. J. A proposed clinical and biological interpretation of mediated interaction. Eur. J. Epidemiol. 30, 1115\u20131118 (2015).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR106","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/CLEP.S149151","volume":"10","author":"D Bos","year":"2018","unstructured":"Bos, D. et al. Thyroid function and atrial fibrillation: is there a mediating role for epicardial adipose tissue? Clin. Epidemiol. 10, 225\u2013234 (2018).","journal-title":"Clin. Epidemiol."},{"key":"967_CR107","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10654-022-00864-7","volume":"37","author":"Y Ma","year":"2022","unstructured":"Ma, Y. et al. APOE \u03b54 and late-life cognition: mediation by structural brain imaging markers. Eur. J. Epidemiol. 37, 591\u2013601 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR108","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/cdev.12660","volume":"88","author":"D Berry","year":"2017","unstructured":"Berry, D. & Willoughby, M. T. On the practical interpretability of cross-lagged panel models: rethinking a developmental workhorse. Child. Dev. 88, 1186\u20131206 (2017).","journal-title":"Child. Dev."},{"key":"967_CR109","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1037\/a0038889","volume":"20","author":"EL Hamaker","year":"2015","unstructured":"Hamaker, E. L., Kuiper, R. M. & Grasman, R. P. A critique of the cross-lagged panel model. Psychol. Methods 20, 102\u2013116 (2015).","journal-title":"Psychol. Methods"},{"key":"967_CR110","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.ajkd.2022.09.007","volume":"81","author":"AM Murray","year":"2023","unstructured":"Murray, A. M. & Vemuri, P. Kidney disease and brain health: current knowledge and next steps. Am. J. Kidney Dis. 81, 253\u2013255 (2023).","journal-title":"Am. J. Kidney Dis."},{"key":"967_CR111","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2024.10.091","volume":"85","author":"FR Mc Causland","year":"2025","unstructured":"Mc Causland, F. R. et al. Finerenone and kidney outcomes in patients with heart failure: the FINEARTS-HF trial. J. Am. Coll. Cardiol. 85, 159\u2013168 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"967_CR112","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/jama.2018.3024","volume":"319","author":"SL Zheng","year":"2018","unstructured":"Zheng, S. L. et al. Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis. JAMA 319, 1580\u20131591 (2018).","journal-title":"JAMA"},{"key":"967_CR113","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12933-023-01877-6","volume":"22","author":"M Sohn","year":"2023","unstructured":"Sohn, M., Dietrich, J. W., Nauck, M. A. & Lim, S. Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study. Cardiovasc. Diabetol. 22, 153 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"967_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.697","volume":"5","author":"KM Sheets","year":"2022","unstructured":"Sheets, K. M., Davey, C. S., St Peter, W. L., Reule, S. A. & Murray, A. M. Cognitive impairment, perceived medication adherence, and high-risk medication use in patients with reduced kidney function: a cross-sectional analysis. Health Sci. Rep. 5, e697 (2022).","journal-title":"Health Sci. Rep."},{"key":"967_CR115","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2022.04.015","volume":"101","author":"S Copur","year":"2022","unstructured":"Copur, S., Berkkan, M., Sarafidis, P. & Kanbay, M. Intensive blood pressure control on dementia in patients with chronic kidney disease: potential reduction in disease burden. Eur. J. Intern. Med. 101, 8\u201313 (2022).","journal-title":"Eur. J. Intern. Med."},{"key":"967_CR116","doi-asserted-by":"publisher","first-page":"S443","DOI":"10.3233\/JAD-141542","volume":"42","author":"MA van Buchem","year":"2014","unstructured":"van Buchem, M. A. et al. The heart\u2013brain connection: a multidisciplinary approach targeting a missing link in the pathophysiology of vascular cognitive impairment. J. Alzheimers Dis. 42, S443\u2013S451 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"967_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24200","volume":"47","author":"CM Nijskens","year":"2024","unstructured":"Nijskens, C. M. et al. Is it time for Heart\u2013Brain clinics? A clinical survey and proposition to improve current care for cognitive problems in heart failure. Clin. Cardiol. 47, e24200 (2024).","journal-title":"Clin. Cardiol."},{"key":"967_CR118","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1681\/ASN.0000000000000359","volume":"35","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Neighborhood racial and ethnic segregation and the risk of dementia in older adults living with kidney failure. J. Am. Soc. Nephrol. 35, 936\u2013948 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"967_CR119","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/ije\/dyp192","volume":"38","author":"SL Taubman","year":"2009","unstructured":"Taubman, S. L., Robins, J. M., Mittleman, M. A. & Hern\u00e1n, M. A. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int. J. Epidemiol. 38, 1599\u20131611 (2009).","journal-title":"Int. J. Epidemiol."},{"key":"967_CR120","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s12561-011-9040-7","volume":"3","author":"JG Young","year":"2011","unstructured":"Young, J. G., Cain, L. E., Robins, J. M., O\u2019Reilly, E. J. & Hern\u00e1n, M. A. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat. Biosci. 3, 119\u2013143 (2011).","journal-title":"Stat. Biosci."},{"key":"967_CR121","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ije\/dyx086","volume":"46","author":"AI Naimi","year":"2017","unstructured":"Naimi, A. I., Cole, S. R. & Kennedy, E. H. An introduction to g methods. Int. J. Epidemiol. 46, 756\u2013762 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"967_CR122","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/rssb.12194","volume":"79","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele, T. J. & Tchetgen Tchetgen, E. J. Mediation analysis with time varying exposures and mediators. J. R. Stat. Soc. Ser. B Stat. Methodol. 79, 917\u2013938 (2017).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"967_CR123","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins, J. M., Hern\u00e1n, M. A. & Brumback, B. Marginal structural models and causal inference in epidemiology. Epidemiology 11, 550\u2013560 (2000).","journal-title":"Epidemiology"},{"key":"967_CR124","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/jamacardio.2023.3142","volume":"8","author":"RM Wehbe","year":"2023","unstructured":"Wehbe, R. M. et al. Deep learning for cardiovascular imaging: a review. JAMA Cardiol. 8, 1089\u20131098 (2023).","journal-title":"JAMA Cardiol."},{"key":"967_CR125","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12933-023-01985-3","volume":"22","author":"EK Oikonomou","year":"2023","unstructured":"Oikonomou, E. K. & Khera, R. Machine learning in precision diabetes care and cardiovascular risk prediction. Cardiovasc. Diabetol. 22, 259 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"967_CR126","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMra2302038","volume":"388","author":"CJ Haug","year":"2023","unstructured":"Haug, C. J. & Drazen, J. M. Artificial intelligence and machine learning in clinical medicine, 2023. N. Engl. J. Med. 388, 1201\u20131208 (2023).","journal-title":"N. Engl. J. Med."},{"key":"967_CR127","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/S2589-7500(23)00241-8","volume":"6","author":"R Giddings","year":"2024","unstructured":"Giddings, R. et al. Factors influencing clinician and patient interaction with machine learning-based risk prediction models: a systematic review. Lancet Digit. Health 6, e131\u2013e144 (2024).","journal-title":"Lancet Digit. Health"},{"key":"967_CR128","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","volume":"34","author":"TJ VanderWeele","year":"2019","unstructured":"VanderWeele, T. J. Principles of confounder selection. Eur. J. Epidemiol. 34, 211\u2013219 (2019).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR129","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10654-019-00564-9","volume":"35","author":"SH Lin","year":"2020","unstructured":"Lin, S. H. & Ikram, M. A. On the relationship of machine learning with causal inference. Eur. J. Epidemiol. 35, 183\u2013185 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"967_CR130","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41591-024-02902-1","volume":"30","author":"S Feuerriegel","year":"2024","unstructured":"Feuerriegel, S. et al. Causal machine learning for predicting treatment outcomes. Nat. Med. 30, 958\u2013968 (2024).","journal-title":"Nat. Med."},{"key":"967_CR131","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/aje\/kwac108","volume":"191","author":"N Mitra","year":"2022","unstructured":"Mitra, N., Roy, J. & Small, D. The future of causal inference. Am. J. Epidemiol. 191, 1671\u20131676 (2022).","journal-title":"Am. J. Epidemiol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00967-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00967-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00967-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:34:56Z","timestamp":1757172896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-00967-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":131,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-00967-w","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"1 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}